References
- United Kingdom Public Assessment Report, Medicine and Health Products Regulatory. Available from: www.mhra.gov.uk/home/groups/par/documents/…/con108732.pdf [last accessed 10 Sept 2013]
- United States of Pharmacopoeia 30 – National Formulatory 25, Chapter 1150, pp. 617, 3102. Available from: http://forums.pharmacyonesource.com/phos/attachments/phos/pharmacy_ops/1601/1/USP.1150.PharmaceuticalStability.MKT.pdf
- APO. Ranitidine, product monograph. Available from: http://webprod5.hc-sc.gc.ca/dpd-bdpp/item-iteme.do?pm-mp=00005487 [last accessed 10 Feb 2014]
- Customer Medicine Information, Ranitidine Sandoz®. Available from: http://www.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/pages/…/szcranit.pdf [last accessed 15 Oct 2013]
- Tripathi KD. Essentials of medical pharmacology. New Delhi, India: Jaypee Brothers’ Medical Publishers (P) Ltd.; 2009
- Gharti KP, Thapa P, Budhathoki U, Bhargava A. Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm 2012;4:201–8
- Jain S, Srinath MS, Narendra C, et al. Development of a floating dosage form of Ranitidine Hydrochloride by statistical optimization technique. J Young Pharm 2010;2:342–9
- Mastiholimath VS, Dandagi PM, Gadad AP, et al. In vitro and in vivo evaluation of Ranitidine Hydrochloride ethyl cellulose floating micro particles. J Microencapsul 2008;25:307–14
- Patel R, Singh R, Panchal KM, et al. Formulation and optimization of floating matrix tablet of ranitidine hydrochloride. Int J Comprehensive Pharm 2011;2:1–5
- Raval JA, Patel JK, Naihong L, Patel MM. Ranitidine hydrochloride floating matrix tablets based on low density powder: effects of formulation and processing parameters on drug release. Asian J Pharm Sci 2007;2:130–142
- Saravanan M, Anupama B. Development and evaluation of ethyl cellulose floating microsphere loaded with ranitidine hydrochloride by novel solvent evaporation-matrix erosion method. Carbohydr Polym 2011;85:592–8
- Aslani A, Jahangiri H. Formulation, characterization and physicochemical evaluation of ranitidine effervescent tablets. Adv Pharm Bull 2013;3:315–22
- Chauhan MS, Kumar A, Pathak K. Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design. AAPS PharmSciTech 2012;13:1492–501
- Dave BS, Amin AF, Patel MM. Gastro retentive drug delivery system of ranitidine hydrochloride: formulation and in-vitro evaluation. AAPS PharmSciTech 2004;5:77–82
- Gnanaprakash K, Chandhrashekhar KB, Madhusudhan CC. Floating tablets of ranitidine HCl with natural polymer: an approach for gastric treatment. Int J Pharm Health Sci 2010;1:109–15
- Hooda A, Nanda A, Jain M, et al. Optimization and evaluation of gastro retentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol 2012;51:691–700
- Ingale RD, Thakare VM, Tekade BW, Patil VR. Development and evaluation of ranitidine hydrochloride floating tablet. Int J Pharm Sci Res 2014;5:269–74
- Kortejarvi H, Yliperttula M, Dressman JB, et al. Bio waiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride. J Pharm Sci 2005;94:1617–25
- Shahiwala A, Roy P. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci 2009;37:363–9
- Sam C, Ramon JP. Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug. Int J Pharm 1997;152:215–25
- Rahman Z, Ali M, Khar RK. Design and evaluation of bilayer floating tablets of captopril. Acta Pharm 2006;56:49–57
- Mina IT. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm 2010;74:332–9
- Coffin, Mark, Davis. Ranitidine solid dosage form. PCT patent WO/9522320; 1995
- Mamoru F, Got A. Properties of gastro retentive sustained release tablets prepared by combination of melt/sublimation actions of l-menthol and penetration of molten polymers into tablets. Chem Pharm Bull 2011;59:1221–6
- Oh T-O, Kim J-Y, Ha J-M, et al. Preparation of highly porous gastro retentive metformin tablets using a sublimation method. Eur J Pharm Biopharm 2013;83:460–7
- Kei-ichi K, Yoshiteru W, Kumiko M, et al. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm 1997;152:127–31
- Patrick L. Gastro esophageal reflux disease (GERD): a review of conventional and alternative treatments. Alt Med Rev 2011;16:116–33
- Scott T. Stomach and duodenal ulcers. Available from: http://www.brooklyngi.com…Stomach%20and%20duodenal%20ulcers.pdf [last accessed 6 Oct 2013]
- National Health Institute, U.S. Department of Health and Human Services. What I need to know about peptic ulcers. National digestive diseases information clearinghouse. Available from: www.digestive.niddk.nih.gov [last accessed 4 Oct 2013]
- Ertan A. What is gastric Esophagitis? Available from: www.atillaertan.comBarretts…What%20is%20Reflux%20Esophagitis.pdf [last accessed 20 Oct 2013]
- National Digestive Diseases Information Clearinghouse. Zollinger-Ellison syndrome. Chicago, Illinois. Available from: www.atillaertan.comBarretts…What%20is%20Reflux%20Esophagitis.pdf [last accessed 24 Oct 2013]
- Inactive ingredient search for approved dug products. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm [last accessed 16 Aug 2013]
- Material safety data sheet. Available from: http://datasheets.scbt.com/sc-204874.pdf [last accessed 15 Feb 2014]
- Orange book: approved drug products with therapeutic equivalence evaluations. Available from: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm [last accessed 5 Aug 2013]
- Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. London, UK: Pharmaceutical Press; 2009
- Anderson M, Whitcomb P. DOE simplified: practical tools for effective experimentation. Available from: http://www.statease.com/pubs/doesimp2excerpt–chap3.pdf [last accessed 23 Dec 2013]
- Patel VP, Shihora HD. Experimental design & patent. Gujarat, India: Akshat Publication & Distributors; 2012
- Aulton ME. Pharmaceutics: the science of dosage form design. London, UK: Churchill Livingstone; 2001:197–210
- FDA. FDA approved drug products. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm [last accessed 7 Aug 2013]
- Hagemann RC, Threlkeld DS. Drug facts and comparisons. 50th ed. Alphen aan den Rijn, Netherlands: Wolters Kluwer Co.; 1996
- Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Biopharm 2001;13:123–33
- Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modelling on drug release from controlled drug delivery systems. Acta Poloniae Pharm 2010;67:217–23
- Korsmeyer RW, Peppas NA, Gurny R, et al. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35
- Pavia DL, Lampman GM, Kriz GS. Introduction to spectroscopy. London, UK: Thomson Learning Inc.; 2001
- Halls. Available from: http://www.gethalls.com/products/halls/halls_df.aspx [last accessed 6 March 2014]
- Product information (Lozenges). Available from: http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=86869&lang=eng [last accessed 6 March 2014]
- Product information (Syrup). Available from: http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=75089&lang=eng [last accessed 6 March 2014]
- Reckitt Benckiser, UK. STREPSILS. Available from: http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=74940&lang=eng [last accessed 6 March 2014]
- Vicks VapoDrops Cough Relief. Available from: http://www.vicks.com/products/vapo-family/vapodrops-cough-drops/ [last accessed 6 March 2014]